-
1
-
-
84864570470
-
Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs
-
Bykerk VP, Akhavan P, Hazlewood GS, Schieir O, Dooley A, Haraoui B, et al. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. J Rheumatol 2012;39:1559-82.
-
(2012)
J Rheumatol
, vol.39
, pp. 1559-1582
-
-
Bykerk, V.P.1
Akhavan, P.2
Hazlewood, G.S.3
Schieir, O.4
Dooley, A.5
Haraoui, B.6
-
2
-
-
84864546733
-
Emerging issues in pharmacological management of rheumatoid arthritis: Results of a national needs assessment survey identifying practice variations for the development of Canadian Rheumatology Association clinical practice recommendations
-
Bykerk VP, Schieir O, Akhavan P, Hazlewood GS, Cheng CK, Bombardier C. Emerging issues in pharmacological management of rheumatoid arthritis: Results of a national needs assessment survey identifying practice variations for the development of Canadian Rheumatology Association clinical practice recommendations. J Rheumatol 2012;39:1555-8.
-
(2012)
J Rheumatol
, vol.39
, pp. 1555-1558
-
-
Bykerk, V.P.1
Schieir, O.2
Akhavan, P.3
Hazlewood, G.S.4
Cheng, C.K.5
Bombardier, C.6
-
3
-
-
77956055481
-
2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
-
Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 2569-2581
-
-
Aletaha, D.1
Neogi, T.2
Silman, A.J.3
Funovits, J.4
Felson, D.T.5
Bingham III, C.O.6
-
4
-
-
0023945481
-
The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
-
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
-
(1988)
Arthritis and Rheumatism
, vol.31
, Issue.3
, pp. 315-324
-
-
Arnett, F.C.1
Edworthy, S.M.2
Bloch, D.A.3
McShane, D.J.4
Fries, J.F.5
Cooper, N.S.6
Healey, L.A.7
Kaplan, S.R.8
Liang, M.H.9
Luthra, H.S.10
Medsger Jr., T.A.11
Mitchell, D.M.12
Neustadt, D.H.13
Pinals, R.S.14
Schaller, J.G.15
Sharp, J.T.16
Wilder, R.L.17
Hunder, G.G.18
-
5
-
-
33745686474
-
Adaptation of clinical guidelines: Literature review and proposition for a framework and procedure
-
DOI 10.1093/intqhc/mzi108
-
Fervers B, Burgers JS, Haugh MC, Latreille J, Mlika-Cabanne N, Paquet L, et al. Adaptation of clinical guidelines: Literature review and proposition for a framework and procedure. Int J Qual Health Care 2006;18:167-76. (Pubitemid 43997301)
-
(2006)
International Journal for Quality in Health Care
, vol.18
, Issue.3
, pp. 167-176
-
-
Fervers, B.1
Burgers, J.S.2
Haugh, M.C.3
Latreille, J.4
Mlika-Cabanne, N.5
Paquet, L.6
Coulombe, M.7
Poirier, M.8
Burnand, B.9
-
6
-
-
84887542094
-
-
Ottawa: Canadian Agency for Drugs and Technology in Health; [Internet. Accessed April 5, 2012.] Available from
-
Canadian Agency for Drugs and Technology in Health. Grey matters: A practical search tool for evidence-based medicine. Ottawa: Canadian Agency for Drugs and Technology in Health; 2009. [Internet. Accessed April 5, 2012.] Available from: http://www.cadth.ca/en/resources/grey-matters
-
(2009)
Grey Matters: A Practical Search Tool for Evidence-based Medicine
-
-
-
7
-
-
0037323867
-
Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE project
-
AGREE Collaboration
-
AGREE Collaboration. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: The AGREE project. Qual Saf Health Care 2003;12:18-23.
-
(2003)
Qual Saf Health Care
, vol.12
, pp. 18-23
-
-
-
8
-
-
0003562478
-
-
Edinburgh: Scottish Intercollegiate Guidelines Network; [Internet. Accessed March 30, 2012.] Available from
-
Scottish Intercollegiate Guidelines Network (SIGN). SIGN 50: A guideline developer's handbook. Edinburgh: Scottish Intercollegiate Guidelines Network; 2008. [Internet. Accessed March 30, 2012.] Available from: http://www.sign.ac. uk/guidelines/fulltext/50/index.html
-
(2008)
SIGN 50: A Guideline Developer's Handbook
-
-
-
9
-
-
24044445860
-
The guideline implementability appraisal (GLIA): Development of an instrument to identify obstacles to guideline implementation
-
Shiffman RN, Dixon J, Brandt C, Essaihi A, Hsiao A, Michel G, et al. The guideline implementability appraisal (GLIA): Development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Mak 2005;5:23.
-
(2005)
BMC Med Inform Decis Mak
, vol.5
, pp. 23
-
-
Shiffman, R.N.1
Dixon, J.2
Brandt, C.3
Essaihi, A.4
Hsiao, A.5
Michel, G.6
-
10
-
-
0034033055
-
The effects of drugs on wound healing - Part II. Specific classes of drugs and their effect on healing wounds
-
DOI 10.1046/j.1365-4362.2000.00949.x
-
Karukonda SR, Flynn TC, Boh EE, McBurney EI, Russo GG, Millikan LE. The effects of drugs on wound healing - part II. Specific classes of drugs and their effect on healing wounds. Int J Dermatol 2000;39:321-33. (Pubitemid 30335776)
-
(2000)
International Journal of Dermatology
, vol.39
, Issue.5
, pp. 321-333
-
-
Karukonda, S.R.K.1
Flynn, T.C.2
Boh, E.E.3
McBurney, E.I.4
Russo, G.G.5
Millikan, L.E.6
-
11
-
-
34047163955
-
Patients with Rheumatoid Arthritis Undergoing Surgery: How Should We Deal with Antirheumatic Treatment?
-
DOI 10.1016/j.semarthrit.2006.10.003, PII S0049017206001612
-
Pieringer H, Stuby U, Biesenbach G. Patients with rheumatoid arthritis undergoing surgery: How should we deal with antirheumatic treatment? Semin Arthritis Rheum 2007;36:278-86. (Pubitemid 46517632)
-
(2007)
Seminars in Arthritis and Rheumatism
, vol.36
, Issue.5
, pp. 278-286
-
-
Pieringer, H.1
Stuby, U.2
Biesenbach, G.3
-
12
-
-
84655169655
-
Perioperative care for patients with rheumatic diseases
-
Akkara Veetil BM, Bongartz T. Perioperative care for patients with rheumatic diseases. Nat Rev Rheumatol 2011;8:32-41.
-
(2011)
Nat Rev Rheumatol
, vol.8
, pp. 32-41
-
-
Akkara Veetil, B.M.1
Bongartz, T.2
-
13
-
-
45849124232
-
BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists
-
[Internet. Accessed March 30, 2012.] Available from
-
Chakravarty K, McDonald H, Pullar T, Taggart A, Chalmers R, Oliver S, et al. BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists. Rheumatology 2008;47:924-5. [Internet. Accessed March 30, 2012.] Available from: http://rheumatology.oxfordjournals.org/content/suppl/2008/05/31/kel216a.DC1/ kel216b.pdf
-
(2008)
Rheumatology
, vol.47
, pp. 924-925
-
-
Chakravarty, K.1
McDonald, H.2
Pullar, T.3
Taggart, A.4
Chalmers, R.5
Oliver, S.6
-
14
-
-
65549119170
-
British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years)
-
Luqmani R, Hennell S, Estrach C, Basher D, Birrell F, Bosworth A, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Rheumatology 2009;48:436-9.
-
(2009)
Rheumatology
, vol.48
, pp. 436-439
-
-
Luqmani, R.1
Hennell, S.2
Estrach, C.3
Basher, D.4
Birrell, F.5
Bosworth, A.6
-
15
-
-
67549096874
-
Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: Integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
-
Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, et al. Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: Integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis 2009;68:1086-93.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1086-1093
-
-
Visser, K.1
Katchamart, W.2
Loza, E.3
Martinez-Lopez, J.A.4
Salliot, C.5
Trudeau, J.6
-
16
-
-
84873066492
-
-
Madrid: Sociedad Espanola de Reumatologia; [Internet. Accessed March 30, 2012.] Available from
-
Spanish Society of Rheumatology. Update of the clinical practise guideline for the management of rheumatoid arthritis in Spain. Madrid: Sociedad Espanola de Reumatologia; 2007. [Internet. Accessed March 30, 2012.] Available from: http://www.ser.es/practicaClinica/Guias-Practica-Clinica.php
-
(2007)
Update of the Clinical Practise Guideline for the Management of Rheumatoid Arthritis in Spain
-
-
-
17
-
-
0035089096
-
Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery
-
DOI 10.1136/ard.60.3.214
-
Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis 2001;60:214-7. (Pubitemid 32260601)
-
(2001)
Annals of the Rheumatic Diseases
, vol.60
, Issue.3
, pp. 214-217
-
-
Grennan, D.M.1
Gray, J.2
Loudon, J.3
Fear, S.4
-
18
-
-
0027303840
-
Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis
-
Sany J, Anaya JM, Canovas F, Combe B, Jorgensen C, Saker S, et al. Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J Rheumatol 1993;20:1129-32. (Pubitemid 23278162)
-
(1993)
Journal of Rheumatology
, vol.20
, Issue.7
, pp. 1129-1132
-
-
Sany, J.1
Anaya, J.-M.2
Canovas, F.3
Combe, B.4
Jorgensen, C.5
Saker, S.6
Thaury, M.N.7
Gavroy, J.-P.8
-
19
-
-
33644507068
-
Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery
-
Murata K, Yasuda T, Ito H, Yoshida M, Shimizu M, Nakamura T. Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Mod Rheumatol 2006;16:14-9.
-
(2006)
Mod Rheumatol
, vol.16
, pp. 14-19
-
-
Murata, K.1
Yasuda, T.2
Ito, H.3
Yoshida, M.4
Shimizu, M.5
Nakamura, T.6
-
20
-
-
0025767122
-
Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis?
-
Bridges SL Jr, Lopez-Mendez A, Han KH, Tracy IC, Alarcon GS. Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J Rheumatol 1991;18:984-8.
-
(1991)
J Rheumatol
, vol.18
, pp. 984-988
-
-
Bridges Jr., S.L.1
Lopez-Mendez, A.2
Han, K.H.3
Tracy, I.C.4
Alarcon, G.S.5
-
21
-
-
0029981838
-
Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy
-
Carpenter MT, West SG, Vogelgesang SA, Casey Jones DE. Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics 1996;19:207-10. (Pubitemid 26089384)
-
(1996)
Orthopedics
, vol.19
, Issue.3
, pp. 207-210
-
-
Carpenter, M.T.1
West, S.G.2
Vogelgesang, S.A.3
Jones, D.E.C.4
-
22
-
-
84873071535
-
-
Sydney: Australian Rheumatology Association; [Internet. Accessed April 2, 2012.] Available from
-
Australian Rheumatology Association. Updated recommendations for the use of biological agents for the treatment of rheumatic diseases. Sydney: Australian Rheumatology Association; 2010. [Internet. Accessed April 2, 2012.] Available from: http://www.rheumatology.org.au/downloads/FINAL-biological- recommendations060111.pdf
-
(2010)
Updated Recommendations for the Use of Biological Agents for the Treatment of Rheumatic Diseases
-
-
-
24
-
-
68549105886
-
Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
-
Koike R, Harigai M, Atsumi T, Amano K, Kawai S, Saito K, et al. Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis. Mod Rheumatol 2009;19:351-7.
-
(2009)
Mod Rheumatol
, vol.19
, pp. 351-357
-
-
Koike, R.1
Harigai, M.2
Atsumi, T.3
Amano, K.4
Kawai, S.5
Saito, K.6
-
25
-
-
14044260093
-
Update on the British Society for Rheumatology guidelines for prescribing TNFalpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)
-
DOI 10.1093/rheumatology/keh464
-
Ledingham J, Deighton C. Update on the British Society for Rheumatology guidelines for prescribing TNF alpha blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology 2005;44:157-63. (Pubitemid 40277395)
-
(2005)
Rheumatology
, vol.44
, Issue.2
, pp. 157-163
-
-
Ledingham, J.1
Deighton, C.2
-
26
-
-
33745937104
-
Consensus on the use and monitoring of anti-TNF-alpha therapies for rheumatic diseases in Hong Kong 2005
-
DOI 10.1111/j.1479-8077.2006.00194.x
-
Mok CC. Consensus on the use and monitoring of anti-TNF-alpha therapies for rheumatic diseases in Hong Kong 2005. APLAR J Rheumatol 2006;9:175-80. (Pubitemid 44057336)
-
(2006)
APLAR Journal of Rheumatology
, vol.9
, Issue.2
, pp. 175-180
-
-
Mok, C.C.1
-
27
-
-
77953599279
-
Tocilizumab: Therapy and safety management
-
Pham T, Claudepierre P, Constantin A, de Bandt M, Fautrel B, Gossec L, et al. Tocilizumab: Therapy and safety management. Joint Bone Spine 2010;77 Suppl 1:S3-100.
-
(2010)
Joint Bone Spine
, vol.77
, Issue.SUPPL. 1
-
-
Pham, T.1
Claudepierre, P.2
Constantin, A.3
De Bandt, M.4
Fautrel, B.5
Gossec, L.6
-
28
-
-
67649794587
-
Abatacept therapy and safety management
-
Pham T, Claudepierre P, Constantin A, Fautrel B, Gossec L, Gottenberg JE, et al. Abatacept therapy and safety management. Joint Bone Spine 2009;76 Suppl 1:S3-S55.
-
(2009)
Joint Bone Spine
, vol.76
, Issue.SUPPL. 1
-
-
Pham, T.1
Claudepierre, P.2
Constantin, A.3
Fautrel, B.4
Gossec, L.5
Gottenberg, J.E.6
-
29
-
-
58849146669
-
Rituximab (MabThera) therapy and safety management. Clinical tool guide
-
Pham T, Fautrel B, Gottenberg JE, Goupille P, Hachulla E, Masson C, et al. Rituximab (MabThera) therapy and safety management. Clinical tool guide. Joint Bone Spine 2008;75 Suppl 1:S1-99.
-
(2008)
Joint Bone Spine
, vol.75
, Issue.SUPPL. 1
-
-
Pham, T.1
Fautrel, B.2
Gottenberg, J.E.3
Goupille, P.4
Hachulla, E.5
Masson, C.6
-
31
-
-
45349090538
-
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis
-
DOI 10.1002/art.23721
-
Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis [review]. Arthritis Care Res 2008;59:762-84. (Pubitemid 351847559)
-
(2008)
Arthritis Care and Research
, vol.59
, Issue.6
, pp. 762-784
-
-
Saag, K.G.1
Gim, G.T.2
Patkar, N.M.3
Anuntiyo, J.4
Finney, C.5
Curtis, J.R.6
Paulus, H.E.7
Mudano, A.8
Pisu, M.9
Elkins-Melton, M.10
Outman, R.11
Allison, J.J.12
Almazor, M.S.13
Bridges Jr., S.L.14
Chatham, W.W.15
Hochberg, M.16
Maclean, C.17
Mikuls, T.18
Moreland, L.W.19
O'Dell, J.20
Turkiewicz, A.M.21
Furst, D.E.22
more..
-
32
-
-
73349122592
-
Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis
-
Spanish Society of Rheumatology.
-
Spanish Society of Rheumatology. Update of the Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in rheumatoid arthritis. Reumatologia Clinica 2010;6:23-36.
-
(2010)
Reumatologia Clinica
, vol.6
, pp. 23-36
-
-
-
33
-
-
27244434053
-
Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Societe Francaise de Rhumatologie, SFR)
-
Pham T, Claudepierre P, Deprez X, Fautrel B, Goupille P, Hilliquin P, et al. Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Societe Francaise de Rhumatologie, SFR). Joint Bone Spine 2005;72 Suppl 1:S1-58.
-
(2005)
Joint Bone Spine
, vol.72
, Issue.SUPPL. 1
-
-
Pham, T.1
Claudepierre, P.2
Deprez, X.3
Fautrel, B.4
Goupille, P.5
Hilliquin, P.6
-
34
-
-
34247338122
-
Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: A large retrospective study
-
den Broeder AA, Creemers MC, Fransen J, de Jong E, de Rooij DJ, Wymenga A, et al. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: A large retrospective study. J Rheumatol 2007;34:689-95. (Pubitemid 46641372)
-
(2007)
Journal of Rheumatology
, vol.34
, Issue.4
, pp. 689-695
-
-
Den, B.A.A.1
Creemers, M.C.W.2
Fransen, J.3
De Jong, E.4
De Rooij, D.-J.R.5
Wymenga, A.6
De Waal-Malefijt, M.7
Van Den, H.F.H.J.8
-
35
-
-
33645904180
-
Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis
-
Giles JT, Bartlett SJ, Gelber AC, Nanda S, Fontaine K, Ruffing V, et al. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Rheum 2006;55:333-7.
-
(2006)
Arthritis Rheum
, vol.55
, pp. 333-337
-
-
Giles, J.T.1
Bartlett, S.J.2
Gelber, A.C.3
Nanda, S.4
Fontaine, K.5
Ruffing, V.6
-
36
-
-
3342881856
-
Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy
-
Bibbo C, Goldberg JW. Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy. Foot Ankle Int 2004;25:331-5. (Pubitemid 39096154)
-
(2004)
Foot and Ankle International
, vol.25
, Issue.5
, pp. 331-335
-
-
Bibbo, C.1
Goldberg, J.W.2
-
37
-
-
0038076340
-
Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection
-
Long R, Gardam M. Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection. CMAJ 2003;168:1153-6. (Pubitemid 36543228)
-
(2003)
Canadian Medical Association Journal
, vol.168
, Issue.9
, pp. 1153-1156
-
-
Long, R.1
Gardam, M.2
-
38
-
-
0035846326
-
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent
-
Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 2001;345:1098-104.
-
(2001)
N Engl J Med
, vol.345
, pp. 1098-1104
-
-
Keane, J.1
Gershon, S.2
Wise, R.P.3
Mirabile-Levens, E.4
Kasznica, J.5
Schwieterman, W.D.6
-
39
-
-
22244454407
-
Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden
-
DOI 10.1002/art.21137
-
Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Coster L, et al. Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum 2005;52:1986-92. (Pubitemid 40994319)
-
(2005)
Arthritis and Rheumatism
, vol.52
, Issue.7
, pp. 1986-1992
-
-
Askling, J.1
Fored, C.M.2
Brandt, L.3
Baecklund, E.4
Bertilsson, L.5
Coster, L.6
Geborek, P.7
Jacobsson, L.T.8
Lindblad, S.9
Lysholm, J.10
Rantapaa-Dahlqvist, S.11
Saxne, T.12
Romanus, V.13
Klareskog, L.14
Feltelius, N.15
-
40
-
-
62549155817
-
Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada
-
Brassard P, Lowe AM, Bernatsky S, Kezouh A, Suissa S. Rheumatoid arthritis, its treatments, and the risk of tuberculosis in Quebec, Canada. Arthritis Rheum 2009;61:300-4.
-
(2009)
Arthritis Rheum
, vol.61
, pp. 300-304
-
-
Brassard, P.1
Lowe, A.M.2
Bernatsky, S.3
Kezouh, A.4
Suissa, S.5
-
41
-
-
0038300694
-
Increased risk of tuberculosis in patients with rheumatoid arthritis
-
Carmona L, Hernandez-Garcia C, Vadillo C, Pato E, Balsa A, Gonzalez-Alvaro I, et al. Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 2003;30:1436-9. (Pubitemid 36835436)
-
(2003)
Journal of Rheumatology
, vol.30
, Issue.7
, pp. 1436-1439
-
-
Carmona, L.1
Hernandez-Garcia, C.2
Vadillo, C.3
Pato, E.4
Balsa, A.5
Gonzalez-Alvaro, I.6
Belmonte, M.A.7
Tena, X.8
Sanmarti, R.9
-
42
-
-
77949477575
-
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: Results from the British Society for Rheumatology Biologics Register (BSRBR)
-
Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A, et al. Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: Results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis 2010;69:522-8.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 522-528
-
-
Dixon, W.G.1
Hyrich, K.L.2
Watson, K.D.3
Lunt, M.4
Galloway, J.5
Ustianowski, A.6
-
43
-
-
34250656516
-
Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection
-
DOI 10.1002/art.22768
-
Gomez-Reino JJ, Carmona L, Angel Descalzo M. Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection. Arthritis Rheum 2007;57:756-61. (Pubitemid 46932080)
-
(2007)
Arthritis Care and Research
, vol.57
, Issue.5
, pp. 756-761
-
-
Gomez-Reino, J.J.1
Carmona, L.2
Descalzo, M.A.3
-
44
-
-
0041653315
-
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors
-
may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report.
-
Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD. Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: A multicenter active-surveillance report. Arthritis Rheum 2003;48:2122-7.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 2122-2127
-
-
Gomez-Reino, J.J.1
Carmona, L.2
Valverde, V.R.3
Mola, E.M.4
Montero, M.D.5
-
45
-
-
34247332718
-
Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): Effects of RA itself and of tumor necrosis factor blockers
-
Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS, et al. Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): Effects of RA itself and of tumor necrosis factor blockers. J Rheumatol 2007;34:706-11.
-
(2007)
J Rheumatol
, vol.34
, pp. 706-711
-
-
Seong, S.S.1
Choi, C.B.2
Woo, J.H.3
Bae, K.W.4
Joung, C.L.5
Uhm, W.S.6
-
46
-
-
67650096563
-
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry
-
Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Breban M, et al. Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry. Arthritis Rheum 2009;60:1884-94.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 1884-1894
-
-
Tubach, F.1
Salmon, D.2
Ravaud, P.3
Allanore, Y.4
Goupille, P.5
Breban, M.6
-
47
-
-
1042290327
-
Tuberculosis Infection in Patients with Rheumatoid Arthritis and the Effect of Infliximab Therapy
-
DOI 10.1002/art.20009
-
Wolfe F, Michaud K, Anderson J, Urbansky K. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 2004;50:372-9. (Pubitemid 38198820)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.2
, pp. 372-379
-
-
Wolfe, F.1
Michaud, K.2
Anderson, J.3
Urbansky, K.4
-
48
-
-
33751274843
-
Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan
-
DOI 10.1136/ard.2005.047274
-
Yamada T, Nakajima A, Inoue E, Tanaka E, Hara M, Tomatsu T, et al. Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan. Ann Rheum Dis 2006;65:1661-3. (Pubitemid 44799684)
-
(2006)
Annals of the Rheumatic Diseases
, vol.65
, Issue.12
, pp. 1661-1663
-
-
Yamada, T.1
Nakajima, A.2
Inoue, E.3
Tanaka, E.4
Hara, M.5
Tomatsu, T.6
Kamatani, N.7
Yamanaka, H.8
-
49
-
-
79953018875
-
Adverse effects of biologics: A network meta-analysis and Cochrane overview
-
Singh JA, Wells GA, Christensen R, Tanjong Ghogomu E, Maxwell L, Macdonald JK, et al. Adverse effects of biologics: A network meta-analysis and Cochrane overview. Cochrane Database Syst Rev 2011;2:CD008794.
-
(2011)
Cochrane Database Syst Rev
, vol.2
-
-
Singh, J.A.1
Wells, G.A.2
Christensen, R.3
Tanjong Ghogomu, E.4
Maxwell, L.5
Macdonald, J.K.6
-
50
-
-
0003573158
-
-
Ottawa: Public Health Agency of Canada; [Internet.Accessed April 2, 2012.] Available from
-
Public Health Agency of Canada. Canadian Tuberculosis Standards 2007. Ottawa: Public Health Agency of Canada; 2007. [Internet.Accessed April 2, 2012.] Available from: http://www.phac-aspc.gc.ca/tbpc-latb/pubs/tbstand07-eng.php
-
(2007)
Canadian Tuberculosis Standards 2007
-
-
-
51
-
-
79958839671
-
Interferon-gamma release assays for diagnosis of latent tuberculosis infection: Evidence in immune-mediated inflammatory disorders
-
Smith R, Cattamanchi A, Steingart KR, Denkinger C, Dheda K, Winthrop KL, et al. Interferon-gamma release assays for diagnosis of latent tuberculosis infection: Evidence in immune-mediated inflammatory disorders. Curr Opin Rheumatol 2011;23:377-84.
-
(2011)
Curr Opin Rheumatol
, vol.23
, pp. 377-384
-
-
Smith, R.1
Cattamanchi, A.2
Steingart, K.R.3
Denkinger, C.4
Dheda, K.5
Winthrop, K.L.6
-
52
-
-
43949107191
-
Thinking in three dimensions: A web-based algorithm to aid the interpretation of tuberculin skin test results
-
Menzies D, Gardiner G, Farhat M, Greenaway C, Pai M. Thinking in three dimensions: A web-based algorithm to aid the interpretation of tuberculin skin test results. Int J Tuberc Lung Dis 2008;12:498-505. (Pubitemid 351703056)
-
(2008)
International Journal of Tuberculosis and Lung Disease
, vol.12
, Issue.5
, pp. 498-505
-
-
Menzies, D.1
Gardiner, G.2
Farhat, M.3
Greenaway, C.4
Pai, M.5
-
53
-
-
33747044702
-
First Latin American position paper on the pharmacological treatment of rheumatoid arthritis
-
DOI 10.1093/rheumatology/kei500
-
Cardiel MH. First Latin American position paper on the pharmacological treatment of rheumatoid arthritis. Rheumatology 2006;45 Suppl:ii7-ii22. (Pubitemid 44445097)
-
(2006)
Rheumatology
, vol.45
, Issue.SUPPL. 2
-
-
Cardiel, M.H.1
-
54
-
-
36849084023
-
Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis
-
DOI 10.1016/j.jbspin.2007.10.001, PII S1297319X07003119
-
Fautrel B, Pham T, Mouterde G, Le Loet X, Goupille P, Guillemin F, et al. Recommendations of the French Society for Rheumatology regarding TNF alpha antagonist therapy in patients with rheumatoid arthritis. Joint Bone Spine 2007;74:627-37. (Pubitemid 350236029)
-
(2007)
Joint Bone Spine
, vol.74
, Issue.6
, pp. 627-637
-
-
Fautrel, B.1
Pham, T.2
Mouterde, G.3
Le, L.X.4
Goupille, P.5
Guillemin, F.6
Ravaud, P.7
Cantagrel, A.8
Dougados, M.9
Puechal, X.10
Sibilia, J.11
Soubrier, M.12
Mariette, X.13
Combe, B.14
-
55
-
-
75749141648
-
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009
-
Furst DE, Keystone EC, Fleischmann R, Mease P, Breedveld FC, Smolen JS, et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009. Ann Rheum Dis 2010;69 Suppl 1:i2-29.
-
(2010)
Ann Rheum Dis
, vol.69
, Issue.SUPPL. 1
-
-
Furst, D.E.1
Keystone, E.C.2
Fleischmann, R.3
Mease, P.4
Breedveld, F.C.5
Smolen, J.S.6
-
56
-
-
84873073482
-
-
Victoria, BC: British Columbia Ministry of Health; 2006. [Internet. Accessed April 2, 2012.] Available from
-
Guidelines and Protocols Advisory Committee. Rheumatoid arthritis: diagnosis and management; 2006. Victoria, BC: British Columbia Ministry of Health; 2006. [Internet. Accessed April 2, 2012.] Available from: http://www.bcguidelines.ca/guideline-ra.html
-
(2006)
Rheumatoid Arthritis: Diagnosis and Management
-
-
-
57
-
-
67650930350
-
Management of patients with rheumatoid arthritis in Latin America: A consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano de Estudio de Artritis Reumatoide
-
Massardo L, Suarez-Almazor ME, Cardiel MH, Nava A, Levy RA, Laurindo I, et al. Management of patients with rheumatoid arthritis in Latin America: A consensus position paper from Pan-American League of Associations of Rheumatology and Grupo Latino Americano De Estudio De Artritis Reumatoide. J Clin Rheumatol 2009;15:203-10.
-
(2009)
J Clin Rheumatol
, vol.15
, pp. 203-210
-
-
Massardo, L.1
Suarez-Almazor, M.E.2
Cardiel, M.H.3
Nava, A.4
Levy, R.A.5
Laurindo, I.6
-
58
-
-
84992229908
-
Indian Rheumatology Association consensus statement on the management of adults with rheumatoid arthritis
-
Misra R, Sharma BL, Gupta R, Pandya S, Agarwal S, Agarwal P, et al. Indian Rheumatology Association consensus statement on the management of adults with rheumatoid arthritis. Indian J Rheumatol 2008;3 Suppl:S1-S16.
-
(2008)
Indian J Rheumatol
, vol.3
, Issue.SUPPL.
-
-
Misra, R.1
Sharma, B.L.2
Gupta, R.3
Pandya, S.4
Agarwal, S.5
Agarwal, P.6
-
60
-
-
33846877022
-
Consensus statement on the use of rituximab in patients with rheumatoid arthritis
-
DOI 10.1136/ard.2006.061002
-
Smolen JS, Keystone EC, Emery P, Breedveld FC, Betteridge N, Burmester GR, et al. Consensus statement on the use of rituximab in patients with rheumatoid arthritis [review]. Ann Rheum Dis 2007;66:143-50. (Pubitemid 46226045)
-
(2007)
Annals of the Rheumatic Diseases
, vol.66
, Issue.2
, pp. 143-150
-
-
Smolen, J.S.1
Keystone, E.C.2
Emery, P.3
Breedveld, F.C.4
Betteridge, N.5
Burmester, G.R.6
Dougados, M.7
Ferraccioli, G.8
Jaeger, U.9
Klareskog, L.10
Kvien, T.K.11
Martin-Mola, E.12
Pavelka, K.13
Carbonell, J.14
Combe, B.15
Cutolo, M.16
Dorner, T.17
Gause, A.18
Gomez-Reino, J.19
Fernandes, C.G.20
Isaacs, J.D.21
Marenco, J.L.22
Mariette, X.23
Matucci-Cerinic, M.24
Montecucco, C.-M.25
Nusslein, H.26
Ostergaard, M.27
Pascual, E.28
Van Riel, P.29
Rubbert, A.30
Sanmarti, R.31
Sekanecz, Z.32
Tak, P.-P.33
Tony, H.-P.34
Valentini, G.35
Valesini, G.36
more..
-
61
-
-
77953696525
-
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
-
Smolen JS, Landewe R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 964-975
-
-
Smolen, J.S.1
Landewe, R.2
Breedveld, F.C.3
Dougados, M.4
Emery, P.5
Gaujoux-Viala, C.6
-
62
-
-
25444517037
-
BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment
-
British Thoracic Society Standards of Care Committee
-
British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax 2005;60:800-5.
-
(2005)
Thorax
, vol.60
, pp. 800-805
-
-
-
63
-
-
77953694972
-
Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: A systematic literature review informing the EULAR recommendations for the management of RA
-
Nam JL, Winthrop KL, van Vollenhoven RF, Pavelka K, Valesini G, Hensor EM, et al. Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: A systematic literature review informing the EULAR recommendations for the management of RA. Ann Rheum Dis 2010;69:976-86.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 976-986
-
-
Nam, J.L.1
Winthrop, K.L.2
Van Vollenhoven, R.F.3
Pavelka, K.4
Valesini, G.5
Hensor, E.M.6
-
64
-
-
77953994043
-
Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010
-
Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection - United States, 2010. MMWR Recomm Rep 2010;59:1-25.
-
(2010)
MMWR Recomm Rep
, vol.59
, pp. 1-25
-
-
Mazurek, G.H.1
Jereb, J.2
Vernon, A.3
LoBue, P.4
Goldberg, S.5
Castro, K.6
-
65
-
-
72049104198
-
4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: A meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity
-
Ziakas PD, Mylonakis E. 4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: A meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity. Clin Infect Dis 2009;49:1883-9.
-
(2009)
Clin Infect Dis
, vol.49
, pp. 1883-1889
-
-
Ziakas, P.D.1
Mylonakis, E.2
-
66
-
-
77956860976
-
Vaccinations in patients with immune-mediated inflammatory diseases
-
Rahier JF, Moutschen M, Van Gompel A, Van Ranst M, Louis E, Segaert S, et al. Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology 2010;49:1815-27.
-
(2010)
Rheumatology
, vol.49
, pp. 1815-1827
-
-
Rahier, J.F.1
Moutschen, M.2
Van Gompel, A.3
Van Ranst, M.4
Louis, E.5
Segaert, S.6
-
67
-
-
79953161956
-
Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases
-
van Assen S, Elkayam O, Agmon-Levin N, Cervera R, Doran MF, Dougados M, et al. Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases. Autoimmun Rev 2011;10:341-52.
-
(2011)
Autoimmun Rev
, vol.10
, pp. 341-352
-
-
Van Assen, S.1
Elkayam, O.2
Agmon-Levin, N.3
Cervera, R.4
Doran, M.F.5
Dougados, M.6
-
68
-
-
29844450347
-
Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis
-
DOI 10.1093/rheumatology/kei193
-
Kapetanovic MC, Saxne T, Sjoholm A, Truedsson L, Jonsson G, Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology 2006;45:106-11. (Pubitemid 43033885)
-
(2006)
Rheumatology
, vol.45
, Issue.1
, pp. 106-111
-
-
Kapetanovic, M.C.1
Saxne, T.2
Sjoholm, A.3
Truedsson, L.4
Jonsson, G.5
Geborek, P.6
-
69
-
-
79952459799
-
General recommendations on immunization - Recommendations of the Advisory Committee on Immunization Practices (ACIP)
-
Centers for Disease Control and Prevention.
-
Centers for Disease Control and Prevention. General recommendations on immunization - Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011;60:1-64.
-
(2011)
MMWR Recomm Rep
, vol.60
, pp. 1-64
-
-
-
70
-
-
0003859836
-
-
National Advisory Committee on Immunization 7th ed. Ottawa: Public Health Agency of Canada; Available from
-
National Advisory Committee on Immunization. Canadian immunization guide. 7th ed. Ottawa: Public Health Agency of Canada; 2006. Available from: http://www.phac-aspc.gc.ca/publicat/cig-gci/
-
(2006)
Canadian Immunization Guide
-
-
-
71
-
-
79951553465
-
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
-
van Assen S, Agmon-Levin N, Elkayam O, Cervera R, Doran MF, Dougados M, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 2011;70:414-22.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 414-422
-
-
Van Assen, S.1
Agmon-Levin, N.2
Elkayam, O.3
Cervera, R.4
Doran, M.F.5
Dougados, M.6
-
72
-
-
45749112561
-
Use of rituximab for the treatment of rheumatoid arthritis: The Latin American context
-
DOI 10.1093/rheumatology/ken015a
-
Soriano ER, Galarza-Maldonado C, Cardiel MH, Pons-Estel BA, Massardo L, Caballero-Uribe CV, et al. Use of rituximab for the treatment of rheumatoid arthritis: The Latin American context. Rheumatology 2008;47:1097-9. (Pubitemid 351865942)
-
(2008)
Rheumatology
, vol.47
, Issue.7
, pp. 1097-1099
-
-
Soriano, E.R.1
Galarza-Maldonado, C.2
Cardiel, M.H.3
Pons-Estel, B.A.4
Massardo, L.5
Caballero-Uribe, C.V.6
Achurra-Castillo, A.F.7
Barile-Fabris, L.A.8
Chavez-Corrales, J.9
Diaz-Coto, J.F.10
Esteva-Spinetti, M.H.11
Guibert-Toledano, M.12
Palazuelos, I.F.13
Keiserman, M.W.14
Lomonte, A.V.15
Mota, L.M.H.16
Pineda, V.C.17
Alarcon, G.S.18
-
73
-
-
33845620209
-
Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA)
-
DOI 10.1080/17402520600800820, PII T37L065K5M402741
-
Stojanovich L. Influenza vaccination of patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Clin Dev Immunol 2006;13:373-5. (Pubitemid 44950054)
-
(2006)
Clinical and Developmental Immunology
, vol.13
, Issue.2-4
, pp. 373-375
-
-
Stojanovich, L.1
-
74
-
-
0037102949
-
Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations
-
DOI 10.1086/341403
-
Hak E, Nordin J, Wei F, Mullooly J, Poblete S, Strikas R, et al. Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis 2002;35:370-7. (Pubitemid 34852565)
-
(2002)
Clinical Infectious Diseases
, vol.35
, Issue.4
, pp. 370-377
-
-
Hak, E.1
Nordin, J.2
Wei, F.3
Mullooly, J.4
Poblete, S.5
Strikas, R.6
Nichol, K.L.7
-
75
-
-
0032517071
-
Benefits of influenza vaccination for low-, intermediate-, and high- risk senior citizens
-
DOI 10.1001/archinte.158.16.1769
-
Nichol KL, Wuorenma J, von Sternberg T. Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens. Arch Intern Med 1998;158:1769-76. (Pubitemid 28421420)
-
(1998)
Archives of Internal Medicine
, vol.158
, Issue.16
, pp. 1769-1776
-
-
Nichol, K.L.1
Wuorenma, J.2
Von Sternberg, T.3
-
76
-
-
84860829597
-
-
National Advisory Committee on Immunization Ottawa: Public Health Agency of Canada; [Internet. Accessed April 2, 2012.] Available from
-
National Advisory Committee on Immunization. Statement on human papilloma virus vaccine 2007. Ottawa: Public Health Agency of Canada; 2007. [Internet. Accessed April 2, 2012.] Available from: http://www.phac-aspc.gc.ca/publicat/ ccdr-rmtc/07vol33/acs-02/index-eng.php
-
(2007)
Statement on Human Papilloma Virus Vaccine 2007
-
-
-
77
-
-
42449123047
-
The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination
-
DOI 10.1136/ard.2007.077552
-
Gelinck LB, van der Bijl AE, Beyer WE, Visser LG, Huizinga TW, van Hogezand RA, et al. The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination. Ann Rheum Dis 2008;67:713-6. (Pubitemid 351571939)
-
(2008)
Annals of the Rheumatic Diseases
, vol.67
, Issue.5
, pp. 713-716
-
-
Gelinck, L.B.S.1
Van Der, B.A.E.2
Beyer, W.E.P.3
Visser, L.G.4
Huizinga, T.W.J.5
Van Hogezand, R.A.6
Rimmelzwaan, G.F.7
Kroon, F.P.8
-
78
-
-
34047190402
-
Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients
-
DOI 10.1093/rheumatology/kel366
-
Kapetanovic MC, Saxne T, Nilsson JA, Geborek P. Influenza vaccination as model for testing immune modulation induced by anti-TNF and methotrexate therapy in rheumatoid arthritis patients. Rheumatology 2007;46:608-11. (Pubitemid 46523304)
-
(2007)
Rheumatology
, vol.46
, Issue.4
, pp. 608-611
-
-
Kapetanovic, M.C.1
Saxne, T.2
Nilsson, J.-A.3
Geborek, P.4
-
79
-
-
0037079861
-
Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus
-
DOI 10.1086/338043
-
Elkayam O, Paran D, Caspi D, Litinsky I, Yaron M, Charboneau D, et al. Immunogenicity and safety of pneumococcal vaccination in patients with rheumatoid arthritis or systemic lupus erythematosus. Clin Infect Dis 2002;34:147-53. (Pubitemid 34028344)
-
(2002)
Clinical Infectious Diseases
, vol.34
, Issue.2
, pp. 147-153
-
-
Elkayam, O.1
Paran, D.2
Caspi, D.3
Litinsky, I.4
Yaron, M.5
Charboneau, D.6
Rubins, J.B.7
-
80
-
-
1442299282
-
The Effect of Tumor Necrosis Factor Blockade on the Response to Pneumococcal Vaccination in Patients with Rheumatoid Arthritis and Ankylosing Spondylitis
-
DOI 10.1053/j.semarthrit.2003.10.003
-
Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arthritis Rheum 2004;33:283-8. (Pubitemid 38280827)
-
(2004)
Seminars in Arthritis and Rheumatism
, vol.33
, Issue.4
, pp. 283-288
-
-
Elkayam, O.1
Caspi, D.2
Reitblatt, T.3
Charboneau, D.4
Rubins, J.B.5
-
81
-
-
34248643414
-
Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone
-
Visvanathan S, Keenan GF, Baker DG, Levinson AI, Wagner CL. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone. J Rheumatol 2007;34:952-7. (Pubitemid 46774837)
-
(2007)
Journal of Rheumatology
, vol.34
, Issue.5
, pp. 952-957
-
-
Visvanathan, S.1
Keenan, G.F.2
Baker, D.G.3
Levinson, A.I.4
Wagner, C.L.5
-
82
-
-
46849083324
-
Vaccination against influenza in patients with rheumatoid arthritis: The effect of rituximab on the humoral response
-
DOI 10.1136/ard.2007.077461
-
Oren S, Mandelboim M, Braun-Moscovici Y, Paran D, Ablin J, Litinsky I, et al. Vaccination against influenza in patients with rheumatoid arthritis: The effect of rituximab on the humoral response. Ann Rheum Dis 2008;67:937-41. (Pubitemid 351956654)
-
(2008)
Annals of the Rheumatic Diseases
, vol.67
, Issue.7
, pp. 937-941
-
-
Oren, S.1
Mandelboim, M.2
Braun-Moscovici, Y.3
Paran, D.4
Ablin, J.5
Litinsky, I.6
Comaneshter, D.7
Levartovsky, D.8
Mendelson, E.9
Azar, R.10
Wigler, I.11
Balbir-Gurman, A.12
Caspi, D.13
Elkayam, O.14
-
83
-
-
74849103999
-
Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab
-
van Assen S, Holvast A, Benne CA, Posthumus MD, van Leeuwen MA, Voskuyl AE, et al. Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab. Arthritis Rheum 2010;62:75-81.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 75-81
-
-
Van Assen, S.1
Holvast, A.2
Benne, C.A.3
Posthumus, M.D.4
Van Leeuwen, M.A.5
Voskuyl, A.E.6
-
84
-
-
74849096560
-
Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial
-
Bingham CO 3rd, Looney RJ, Deodhar A, Halsey N, Greenwald M, Codding C, et al. Immunization responses in rheumatoid arthritis patients treated with rituximab: Results from a controlled clinical trial. Arthritis Rheum 2010;62:64-74.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 64-74
-
-
Bingham III, C.O.1
Looney, R.J.2
Deodhar, A.3
Halsey, N.4
Greenwald, M.5
Codding, C.6
-
85
-
-
44049085950
-
A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis
-
Smitten AL, Simon TA, Hochberg MC, Suissa S. A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis. Arthritis Res Ther 2008;10:R45.
-
(2008)
Arthritis Res Ther
, vol.10
-
-
Smitten, A.L.1
Simon, T.A.2
Hochberg, M.C.3
Suissa, S.4
-
86
-
-
41649100103
-
Malignancy and biologic therapy in rheumatoid arthritis
-
DOI 10.1097/BOR.0b013e3282f7c706, PII 0000228120080500000018
-
Askling J, Bongartz T. Malignancy and biologic therapy in rheumatoid arthritis. Curr Opin Rheumatol 2008;20:334-9. (Pubitemid 351483325)
-
(2008)
Current Opinion in Rheumatology
, vol.20
, Issue.3
, pp. 334-339
-
-
Askling, J.1
Bongartz, T.2
-
87
-
-
33644892763
-
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
-
Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, et al. Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006;54:692-701.
-
(2006)
Arthritis Rheum
, vol.54
, pp. 692-701
-
-
Baecklund, E.1
Iliadou, A.2
Askling, J.3
Ekbom, A.4
Backlin, C.5
Granath, F.6
-
88
-
-
33646696885
-
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
-
DOI 10.1001/jama.295.19.2275
-
Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295:2275-85. (Pubitemid 43736578)
-
(2006)
Journal of the American Medical Association
, vol.295
, Issue.19
, pp. 2275-2285
-
-
Bongartz, T.1
Sutton, A.J.2
Sweeting, M.J.3
Buchan, I.4
Matteson, E.L.5
Montori, V.6
-
89
-
-
67549122368
-
Etanercept therapy in rheumatoid arthritis and the risk of malignancies: A systematic review and individual patient data meta-analysis of randomised controlled trials
-
Bongartz T, Warren FC, Mines D, Matteson EL, Abrams KR, Sutton AJ. Etanercept therapy in rheumatoid arthritis and the risk of malignancies: A systematic review and individual patient data meta-analysis of randomised controlled trials. Ann Rheum Dis 2009;68:1177-83.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1177-1183
-
-
Bongartz, T.1
Warren, F.C.2
Mines, D.3
Matteson, E.L.4
Abrams, K.R.5
Sutton, A.J.6
-
90
-
-
78751685797
-
Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: Meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data
-
Askling J, Fahrbach K, Nordstrom B, Ross S, Schmid CH, Symmons D. Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: Meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data. Pharmacoepidemiol Drug Saf 2011;20:119-30.
-
(2011)
Pharmacoepidemiol Drug Saf
, vol.20
, pp. 119-130
-
-
Askling, J.1
Fahrbach, K.2
Nordstrom, B.3
Ross, S.4
Schmid, C.H.5
Symmons, D.6
-
91
-
-
80053565309
-
Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: A systematic review and meta-analysis
-
Mariette X, Matucci-Cerinic M, Pavelka K, Taylor P, van Vollenhoven R, Heatley R, et al. Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: A systematic review and meta-analysis. Ann Rheum Dis 2011;70:1895-904.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 1895-1904
-
-
Mariette, X.1
Matucci-Cerinic, M.2
Pavelka, K.3
Taylor, P.4
Van Vollenhoven, R.5
Heatley, R.6
-
92
-
-
77953103015
-
Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for Rheumatology Biologics Register
-
Dixon WG, Watson KD, Lunt M, Mercer LK, Hyrich KL, Symmons DP. Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for Rheumatology Biologics Register. Arthritis Care Res 2010;62:755-63.
-
(2010)
Arthritis Care Res
, vol.62
, pp. 755-763
-
-
Dixon, W.G.1
Watson, K.D.2
Lunt, M.3
Mercer, L.K.4
Hyrich, K.L.5
Symmons, D.P.6
-
93
-
-
77955479672
-
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT
-
Strangfeld A, Hierse F, Rau R, Burmester GR, Krummel-Lorenz B, Demary W, et al. Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT. Arthritis Res Ther 2010;12:R5.
-
(2010)
Arthritis Res Ther
, vol.12
-
-
Strangfeld, A.1
Hierse, F.2
Rau, R.3
Burmester, G.R.4
Krummel-Lorenz, B.5
Demary, W.6
-
94
-
-
77949673916
-
Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials
-
van Vollenhoven RF, Emery P, Bingham CO 3rd, Keystone EC, Fleischmann R, Furst DE, et al. Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials. J Rheumatol 2010;37:558-67.
-
(2010)
J Rheumatol
, vol.37
, pp. 558-567
-
-
Van Vollenhoven, R.F.1
Emery, P.2
Bingham III, C.O.3
Keystone, E.C.4
Fleischmann, R.5
Furst, D.E.6
-
95
-
-
72249096209
-
Malignancies in the rheumatoid arthritis abatacept clinical development programme: An epidemiological assessment
-
Simon TA, Smitten AL, Franklin J, Askling J, Lacaille D, Wolfe F, et al. Malignancies in the rheumatoid arthritis abatacept clinical development programme: An epidemiological assessment. Ann Rheum Dis 2009;68:1819-26.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1819-1826
-
-
Simon, T.A.1
Smitten, A.L.2
Franklin, J.3
Askling, J.4
Lacaille, D.5
Wolfe, F.6
-
96
-
-
77953108807
-
Avoiding common pitfalls in the analysis of observational studies of new treatments for rheumatoid arthritis
-
Hudson M, Suissa S. Avoiding common pitfalls in the analysis of observational studies of new treatments for rheumatoid arthritis. Arthritis Care Res 2010;62:805-10.
-
(2010)
Arthritis Care Res
, vol.62
, pp. 805-810
-
-
Hudson, M.1
Suissa, S.2
-
97
-
-
57349139451
-
Assessing the safety of new arthritis drugs: Are we there yet?
-
Suissa S. Assessing the safety of new arthritis drugs: Are we there yet? J Rheumatol 2008;35:2295-7.
-
(2008)
J Rheumatol
, vol.35
, pp. 2295-2297
-
-
Suissa, S.1
-
98
-
-
20944444787
-
Physical examination and laboratory tests in the management of patients with rheumatoid arthritis: Development of recommendations for clinical practice based on published evidence and expert opinion
-
DOI 10.1016/j.jbspin.2004.10.010
-
Pham T, Gossec L, Fautrel B, Combe B, Flipo RM, Goupille P, et al. Physical examination and laboratory tests in the management of patients with rheumatoid arthritis: Development of recommendations for clinical practice based on published evidence and expert opinion. Joint Bone Spine 2005;72:222-8. (Pubitemid 40591762)
-
(2005)
Joint Bone Spine
, vol.72
, Issue.3
, pp. 222-228
-
-
Pham, T.1
Gossec, L.2
Fautrel, B.3
Combe, B.4
Flipo, R.-M.5
Goupille, P.6
Le, L.X.7
Mariette, X.8
Puechal, X.9
Wendling, D.10
Schaeverbeke, T.11
Sibilia, J.12
Sany, J.13
Dougados, M.14
-
99
-
-
40449106365
-
Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis
-
DOI 10.1001/archinternmed.2007.107
-
Bernatsky S, Clarke AE, Suissa S. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis. Arch Intern Med 2008;168:378-81. (Pubitemid 351347129)
-
(2008)
Archives of Internal Medicine
, vol.168
, Issue.4
, pp. 378-381
-
-
Bernatsky, S.1
Clarke, A.E.2
Suissa, S.3
-
100
-
-
45349083403
-
Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate
-
DOI 10.1002/art.23716
-
Buchbinder R, Barber M, Heuzenroeder L, Wluka AE, Giles G, Hall S, et al. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum 2008;59:794-9. (Pubitemid 351847561)
-
(2008)
Arthritis Care and Research
, vol.59
, Issue.6
, pp. 794-799
-
-
Buchbinder, R.1
Barber, M.2
Heuzenroeder, L.3
Wluka, A.E.4
Giles, G.5
Hall, S.6
Harkness, A.7
Lewis, D.8
Littlejohn, G.9
Miller, M.H.10
Ryan, P.F.J.11
Jolley, D.12
-
101
-
-
44349093644
-
Cancer in Rheumatoid Arthritis: Occurrence, Mortality, and Associated Factors in a South European Population
-
DOI 10.1016/j.semarthrit.2007.08.006, PII S0049017207001424
-
Abasolo L, Judez E, Descalzo MA, Gonzalez-Alvaro I, Jover JA, Carmona L, et al. Cancer in rheumatoid arthritis: Occurrence, mortality, and associated factors in a South European population. Semin Arthritis Rheum 2008;37:388-97. (Pubitemid 351734521)
-
(2008)
Seminars in Arthritis and Rheumatism
, vol.37
, Issue.6
, pp. 388-397
-
-
Abasolo, L.1
Judez, E.2
Descalzo, M.A.3
Gonzalez-Alvaro, I.4
Jover, J.A.5
Carmona, L.6
-
102
-
-
41849140880
-
Risk of lymphoproliferative cancer among patients with severe rheumatoid arthritis, 1996-2002
-
DOI 10.1136/ard.2007.075986
-
Herrinton LJ, Liu L, Shoor S, Mines D. Risk of lymphoproliferative cancer among patients with severe rheumatoid arthritis, 1996-2002. Ann Rheum Dis 2008;67:574-5. (Pubitemid 351498446)
-
(2008)
Annals of the Rheumatic Diseases
, vol.67
, Issue.4
, pp. 574-575
-
-
Herrinton, L.J.1
Liu, L.2
Shoor, S.3
Mines, D.4
-
103
-
-
2642554059
-
Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients
-
DOI 10.1002/art.20311
-
Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: The effect of methotrexate and anti-tumor necrosis factor therapy in 18,572 patients. Arthritis Rheum 2004;50:1740-51. (Pubitemid 38725085)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.6
, pp. 1740-1751
-
-
Wolfe, F.1
Michaud, K.2
-
104
-
-
66149084485
-
Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: Relative risks and time trends in the Swedish Biologics Register
-
Askling J, Baecklund E, Granath F, Geborek P, Fored M, Backlin C, et al. Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: Relative risks and time trends in the Swedish Biologics Register. Ann Rheum Dis 2009;68:648-53.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 648-653
-
-
Askling, J.1
Baecklund, E.2
Granath, F.3
Geborek, P.4
Fored, M.5
Backlin, C.6
-
105
-
-
33749346419
-
Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis
-
DOI 10.1002/art.22056
-
Setoguchi S, Solomon DH, Weinblatt ME, Katz JN, Avorn J, Glynn RJ, et al. Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:2757-64. (Pubitemid 44497754)
-
(2006)
Arthritis and Rheumatism
, vol.54
, Issue.9
, pp. 2757-2764
-
-
Setoguchi, S.1
Solomon, D.H.2
Weinblatt, M.E.3
Katz, J.N.4
Avorn, J.5
Glynn, R.J.6
Cook, E.F.7
Carney, G.8
Schneeweiss, S.9
-
106
-
-
34248547187
-
The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation
-
DOI 10.1002/art.22579
-
Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation. Arthritis Rheum 2007;56:1433-9. (Pubitemid 46764070)
-
(2007)
Arthritis and Rheumatism
, vol.56
, Issue.5
, pp. 1433-1439
-
-
Wolfe, F.1
Michaud, K.2
-
107
-
-
17644374819
-
Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
-
DOI 10.1136/ard.2004.030528
-
Geborek P, Bladstrom A, Turesson C, Gulfe A, Petersson IF, Saxne T, et al. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis 2005;64:699-703. (Pubitemid 40559295)
-
(2005)
Annals of the Rheumatic Diseases
, vol.64
, Issue.5
, pp. 699-703
-
-
Geborek, P.1
Bladstrom, A.2
Turesson, C.3
Gulfe, A.4
Petersson, I.F.5
Saxne, T.6
Olsson, H.7
Jacobsson, L.T.H.8
-
108
-
-
27744520447
-
Haematopoietic malignancies in rheumatoid arthritis: Lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists
-
DOI 10.1136/ard.2004.033241
-
Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, et al. Haematopoietic malignancies in rheumatoid arthritis: Lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists. Ann Rheum Dis 2005;64:1414-20. (Pubitemid 41623850)
-
(2005)
Annals of the Rheumatic Diseases
, vol.64
, Issue.10
, pp. 1414-1420
-
-
Askling, J.1
Fored, C.M.2
Baecklund, E.3
Brandt, L.4
Backlin, C.5
Ekbom, A.6
Sundstrom, C.7
Bertilsson, L.8
Coster, L.9
Geborek, P.10
Jacobsson, L.T.11
Lindblad, S.12
Lysholm, J.13
Rantapaa-Dahlqvist, S.14
Saxne, T.15
Klareskog, L.16
Feltelius, N.17
-
109
-
-
75849118366
-
Lymphoma in patients treated with anti-TNF: Results of the 3-year prospective French RATIO registry
-
Mariette X, Tubach F, Bagheri H, Bardet M, Berthelot JM, Gaudin P, et al. Lymphoma in patients treated with anti-TNF: Results of the 3-year prospective French RATIO registry. Ann Rheum Dis 2010;69:400-8.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 400-408
-
-
Mariette, X.1
Tubach, F.2
Bagheri, H.3
Bardet, M.4
Berthelot, J.M.5
Gaudin, P.6
-
110
-
-
72449154112
-
Tumour necrosis factor antagonist therapy and cancer development: Analysis of the LORHEN registry
-
Pallavicini FB, Caporali R, Sarzi-Puttini P, Atzeni F, Bazzani C, Gorla R, et al. Tumour necrosis factor antagonist therapy and cancer development: Analysis of the LORHEN registry. Autoimmun Rev 2010;9:175-80.
-
(2010)
Autoimmun Rev
, vol.9
, pp. 175-180
-
-
Pallavicini, F.B.1
Caporali, R.2
Sarzi-Puttini, P.3
Atzeni, F.4
Bazzani, C.5
Gorla, R.6
-
111
-
-
34848893989
-
Biologic treatment of rheumatoid arthritis and the risk of malignancy: Analyses from a large US observational study
-
DOI 10.1002/art.22864
-
Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: Analyses from a large US observational study. Arthritis Rheum 2007;56:2886-95. (Pubitemid 47502734)
-
(2007)
Arthritis and Rheumatism
, vol.56
, Issue.9
, pp. 2886-2895
-
-
Wolfe, F.1
Michaud, K.2
-
112
-
-
70350548170
-
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: Does the risk change with the time since start of treatment?
-
Askling J, van Vollenhoven RF, Granath F, Raaschou P, Fored CM, Baecklund E, et al. Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: Does the risk change with the time since start of treatment? Arthritis Rheum 2009;60:3180-9.
-
(2009)
Arthritis Rheum
, vol.60
, pp. 3180-3189
-
-
Askling, J.1
Van Vollenhoven, R.F.2
Granath, F.3
Raaschou, P.4
Fored, C.M.5
Baecklund, E.6
-
113
-
-
67149120677
-
Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases
-
Burmester GR, Mease P, Dijkmans BAC, Gordon K, Lovell D, Panaccione R, et al. Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases. Ann Rheum Dis 2009;68:1863-9.
-
(2009)
Ann Rheum Dis
, vol.68
, pp. 1863-1869
-
-
Burmester, G.R.1
Mease, P.2
Dijkmans, B.A.C.3
Gordon, K.4
Lovell, D.5
Panaccione, R.6
-
114
-
-
27744527575
-
Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
-
DOI 10.1136/ard.2004.033993
-
Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, et al. Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists. Ann Rheum Dis 2005;64:1421-6. (Pubitemid 41623851)
-
(2005)
Annals of the Rheumatic Diseases
, vol.64
, Issue.10
, pp. 1421-1426
-
-
Askling, J.1
Fored, C.M.2
Brandt, L.3
Baecklund, E.4
Bertilsson, L.5
Feltelius, N.6
Coster, L.7
Geborek, P.8
Jacobsson, L.T.9
Lindblad, S.10
Lysholm, J.11
Rantapaa-Dahlqvist, S.12
Saxne, T.13
Klareskog, L.14
-
115
-
-
38649126529
-
Lung cancer after exposure to disease modifying anti-rheumatic drugs
-
DOI 10.1016/j.lungcan.2007.06.013, PII S0169500207003662
-
Bernatsky S, Clarke A, Suissa S. Lung cancer after exposure to disease modifying anti-rheumatic drugs. Lung Cancer 2008;59:266-9. (Pubitemid 351173401)
-
(2008)
Lung Cancer
, vol.59
, Issue.2
, pp. 266-269
-
-
Bernatsky, S.1
Clarke, A.2
Suissa, S.3
|